CIK 0001745114 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in V8 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-25 | 6-K | 6-K | 2026-06-30 |
| 2026-07-20 | 6-K | FORM 6-K | 2026-07-16 |
| 2026-07-07 | 6-K | FORM 6-K | 2026-07-06 |
| 2026-07-02 | 6-K | FORM 6-K | 2026-07-02 |
| 2026-06-24 | S-8 | S-8 | |
| 2026-06-01 | 6-K | FORM 6-K | 2026-05-30 |
| 2026-05-12 | 6-K | 6-K | 2026-03-31 |
| 2026-05-01 | 6-K | FORM 6-K | 2026-05-01 |
| 2026-04-14 | 6-K | FORM 6-K | 2026-04-14 |
| 2026-03-30 | 6-K | 6-K | 2026-03-31 |
| 2026-03-13 | 6-K | FORM 6-K | 2026-03-12 |
| 2026-03-12 | 6-K | 6-K | 2025-12-31 |
| 2026-03-12 | 20-F | 20-F | 2025-12-31 |
| 2026-02-02 | 6-K | FORM 6-K | 2026-02-02 |
| 2026-01-12 | 6-K | FORM 6-K | 2026-01-11 |
| 2025-12-08 | 6-K | FORM 6-K | 2025-12-07 |
| 2025-11-12 | 6-K | FORM 6-K | 2025-11-12 |
| 2025-10-30 | 6-K | 6-K | 2025-09-30 |
| 2025-08-25 | 6-K | 6-K | 2025-06-30 |
| 2025-07-17 | SCHEDULE 13G | SCHEDULE 13G | |
| 2025-06-25 | S-8 | S-8 | |
| 2025-06-12 | 6-K | 6-K | 2025-06-12 |
| 2025-05-15 | 6-K | 6-K | 2025-03-31 |
| 2025-05-02 | SCHEDULE 13G | SCHEDULE 13G | |
| 2025-04-29 | 6-K | 6-K | 2025-04-29 |
Forms on file (last 1,000): 6-K 67, CORRESP 7, 20-F 5, UPLOAD 5, F-1/A 5, S-8 4, EFFECT 4, SC 13G/A 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=MOLN (0.002 USD), /gw/filings/filings?ticker=MOLN&form=8-K, /gw/filings/facts?ticker=MOLN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange